Sera Prognostics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US81749D1072
USD
2.98
0.08 (2.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

25.73 k

Shareholding (Mar 2025)

FII

3.12%

Held by 24 FIIs

DII

73.98%

Held by 19 DIIs

Promoter

6.47%

How big is Sera Prognostics, Inc.?

22-Jun-2025

As of Jun 18, Sera Prognostics, Inc. has a market capitalization of 69.32 million, with net sales of 0.11 million and a net profit of -32.99 million over the latest four quarters. The company reported shareholder's funds of 47.80 million and total assets of 72.75 million as of Dec 24.

Market Cap: As of Jun 18, Sera Prognostics, Inc. has a market capitalization of 69.32 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Sera Prognostics, Inc. reported net sales of 0.11 million and a net profit of -32.99 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 47.80 million and total assets of 72.75 million.

Read More

What does Sera Prognostics, Inc. do?

22-Jun-2025

Sera Prognostics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $8 million as of March 2025, with a market cap of $69.32 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -34.80%.

Overview:<BR>Sera Prognostics, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -8 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 69.32 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.48 <BR>Return on Equity: -34.80% <BR>Price to Book: 0.73<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Sera Prognostics, Inc. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Sera Prognostics, Inc. shows a neutral trend with mixed signals, outperforming the S&P 500 recently but experiencing significant negative returns year-to-date and over the past year.

As of 9 September 2025, the technical trend for Sera Prognostics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The Bollinger Bands indicate a bullish signal on the weekly chart but bearish on the monthly. Moving averages are mildly bearish on the daily timeframe. The KST shows bullish momentum on both weekly and monthly charts, while Dow Theory presents a mildly bearish view weekly and mildly bullish monthly. The OBV is mildly bearish across both timeframes.<BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 4.23% and 34.45% respectively, compared to the S&P 500's 1.05% and 2.33%. However, year-to-date and one-year returns are significantly negative at -60.69% and -59.13%, respectively, while the S&P 500 has gained 12.22% and 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 121 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.45

stock-summary
Return on Equity

-37.10%

stock-summary
Price to Book

1.37

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.35%
0%
-12.35%
6 Months
56.02%
0%
56.02%
1 Year
-53.58%
0%
-53.58%
2 Years
49.75%
0%
49.75%
3 Years
125.76%
0%
125.76%
4 Years
-70.44%
0%
-70.44%
5 Years
0%
0%
0.0%

Sera Prognostics, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-72.44%
EBIT Growth (5y)
-0.59%
EBIT to Interest (avg)
-32.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
72.86%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.62
EV to EBIT
-0.35
EV to EBITDA
-0.36
EV to Capital Employed
0.26
EV to Sales
12.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-74.84%
ROE (Latest)
-34.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 20 Schemes (16.43%)

Foreign Institutions

Held by 24 Foreign Institutions (3.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 3.61% vs 20.95% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.10",
          "val2": "-8.90",
          "chgp": "-2.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.00",
          "val2": "-8.30",
          "chgp": "3.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-548,235.30%",
          "val2": "-385,541.70%",
          "chgp": "-16,269.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -66.67% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.12% vs 18.10% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.30",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-35.80",
          "val2": "-38.60",
          "chgp": "7.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-32.90",
          "val2": "-36.20",
          "chgp": "9.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-475,779.20%",
          "val2": "-129,153.60%",
          "chgp": "-34,662.56%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-9.10
-8.90
-2.25%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-8.00
-8.30
3.61%
Operating Profit Margin (Excl OI)
-548,235.30%
-385,541.70%
-16,269.36%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 3.61% vs 20.95% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.10
0.30
-66.67%
Operating Profit (PBDIT) excl Other Income
-35.80
-38.60
7.25%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
-0.30
100.00%
Consolidate Net Profit
-32.90
-36.20
9.12%
Operating Profit Margin (Excl OI)
-475,779.20%
-129,153.60%
-34,662.56%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -66.67% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 9.12% vs 18.10% in Dec 2023

stock-summaryCompany CV
About Sera Prognostics, Inc. stock-summary
stock-summary
Sera Prognostics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available